Natus Medical Incorporated
NTUS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $806,203 | $672,582 | $1,111,631 | $907,573 |
| - Cash | $75,595 | $82,082 | $63,297 | $56,373 |
| + Debt | $11,531 | $55,840 | $54,665 | $104,474 |
| Enterprise Value | $742,139 | $646,340 | $1,102,999 | $955,674 |
| Revenue | $473,438 | $415,684 | $495,175 | $530,891 |
| % Growth | 13.9% | -16.1% | -6.7% | – |
| Gross Profit | $273,680 | $216,531 | $291,708 | $304,015 |
| % Margin | 57.8% | 52.1% | 58.9% | 57.3% |
| EBITDA | $49,318 | $9,706 | $14,406 | $8,397 |
| % Margin | 10.4% | 2.3% | 2.9% | 1.6% |
| Net Income | $13,177 | -$16,613 | -$15,671 | -$22,935 |
| % Margin | 2.8% | -4% | -3.2% | -4.3% |
| EPS Diluted | 0.39 | -0.49 | -0.47 | -0.69 |
| % Growth | 179.6% | -4.3% | 31.9% | – |
| Operating Cash Flow | $63,995 | $34,426 | $60,060 | $33,020 |
| Capital Expenditures | -$3,620 | -$8,609 | -$5,339 | -$8,540 |
| Free Cash Flow | $60,375 | $25,817 | $54,721 | $24,480 |